A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|Breast Cancer|Pancreatic Cancer|Prostatic Cancer|Colorectal Cancer
Interventions: DRUG: HS-10502
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.